APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brain Health Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Brain Health Products Market Outlook and Growth Opportunities 2026

30 December 2025194 pages

Choose your research edition.

Industry ResearchBrain Health Products Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Brain Health Products Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Brain Health Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brain Health Products Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Brain Health Products Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Brain Health Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Brain Health Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brain Health Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brain Health Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Brain Health Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Brain Health Products market include Yuwangpharma, Velnex Medicare, Unilever Global, Synergy CHC, Reckitt Benckiser Group plc., Quincy Bioscience, Ocean Health Pte Ltd., Neuriva and Natural Factors, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Brain Health Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brain Health Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brain Health Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Brain Health Products market.

Brain Health Products Segment by Company

Yuwangpharma

Velnex Medicare

Unilever Global

Synergy CHC

Reckitt Benckiser Group plc.

Quincy Bioscience

Ocean Health Pte Ltd.

Neuriva

Natural Factors

Natrol, LLC.

Lifelab Manufacturing

GNC Holdings, LLC

DSM-Firmenich

BL Bio Lab

AdvaCare Pharma

Brain Health Products Segment by Type

Plant Extracts

Fatty Acids

Vitamins

Others

Brain Health Products Segment by Application

Online Sales

Offline Sales

Brain Health Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Brain Health Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Brain Health Products key companies, revenue, market share, and recent developments.

3. To split the Brain Health Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Brain Health Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Brain Health Products significant trends, drivers, influence factors in global and regions.

6. To analyze Brain Health Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain Health Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brain Health Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain Health Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brain Health Products industry.

Chapter 3: Detailed analysis of Brain Health Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Brain Health Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Brain Health Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Brain Health Products Industry Trends Table 2. Brain Health Products Industry Drivers Table 3. Brain Health Products Industry Opportunities and Challenges Table 4. Brain Health Products Industry Restraints Table 5. Global Brain Health Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Brain Health Products Revenue Share by Company (2021-2026) Table 7. Global Brain Health Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Brain Health Products Key Company Manufacturing Base & Headquarters Table 9. Global Brain Health Products Company, Product Type & Application Table 10. Global Brain Health Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Brain Health Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Plant Extracts Table 15. Significant Companies of Fatty Acids Table 16. Significant Companies of Vitamins Table 17. Significant Companies of Others Table 18. Global Brain Health Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Brain Health Products Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Brain Health Products Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Brain Health Products Sales Value Share by Type (2021-2026) Table 22. Global Brain Health Products Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Online Sales Table 24. Significant Companies of Offline Sales Table 25. Global Brain Health Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Brain Health Products Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Brain Health Products Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Brain Health Products Sales Value Share by Application (2021-2026) Table 29. Global Brain Health Products Sales Value Share by Application (2027-2032) Table 30. Global Brain Health Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Brain Health Products Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Brain Health Products Sales Value Share by Region (2021-2026) Table 33. Global Brain Health Products Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Brain Health Products Sales Value Share by Region (2027-2032) Table 35. Global Brain Health Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Brain Health Products Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Brain Health Products Sales Value Market Share by Country (2021-2026) Table 38. Global Brain Health Products Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Brain Health Products Sales Value Market Share by Country (2027-2032) Table 40. Yuwangpharma Company Information Table 41. Yuwangpharma Business Overview Table 42. Yuwangpharma Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Yuwangpharma Brain Health Products Product Portfolio Table 44. Yuwangpharma Recent Development Table 45. Velnex Medicare Company Information Table 46. Velnex Medicare Business Overview Table 47. Velnex Medicare Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Velnex Medicare Brain Health Products Product Portfolio Table 49. Velnex Medicare Recent Development Table 50. Unilever Global Company Information Table 51. Unilever Global Business Overview Table 52. Unilever Global Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Unilever Global Brain Health Products Product Portfolio Table 54. Unilever Global Recent Development Table 55. Synergy CHC Company Information Table 56. Synergy CHC Business Overview Table 57. Synergy CHC Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Synergy CHC Brain Health Products Product Portfolio Table 59. Synergy CHC Recent Development Table 60. Reckitt Benckiser Group plc. Company Information Table 61. Reckitt Benckiser Group plc. Business Overview Table 62. Reckitt Benckiser Group plc. Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Reckitt Benckiser Group plc. Brain Health Products Product Portfolio Table 64. Reckitt Benckiser Group plc. Recent Development Table 65. Quincy Bioscience Company Information Table 66. Quincy Bioscience Business Overview Table 67. Quincy Bioscience Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Quincy Bioscience Brain Health Products Product Portfolio Table 69. Quincy Bioscience Recent Development Table 70. Ocean Health Pte Ltd. Company Information Table 71. Ocean Health Pte Ltd. Business Overview Table 72. Ocean Health Pte Ltd. Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Ocean Health Pte Ltd. Brain Health Products Product Portfolio Table 74. Ocean Health Pte Ltd. Recent Development Table 75. Neuriva Company Information Table 76. Neuriva Business Overview Table 77. Neuriva Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Neuriva Brain Health Products Product Portfolio Table 79. Neuriva Recent Development Table 80. Natural Factors Company Information Table 81. Natural Factors Business Overview Table 82. Natural Factors Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Natural Factors Brain Health Products Product Portfolio Table 84. Natural Factors Recent Development Table 85. Natrol, LLC. Company Information Table 86. Natrol, LLC. Business Overview Table 87. Natrol, LLC. Brain Health Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Natrol, LLC. Brain Health Products Product Portfolio Table 89. Natrol, LLC. Recent Development Table 90. Lifelab Manufacturing Company Information Table 91. Lifelab Manufacturing Business Overview Table 92. Lifelab Manufacturing Brain Health Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Lifelab Manufacturing Brain Health Products Product Portfolio Table 94. Lifelab Manufacturing Recent Development Table 95. GNC Holdings, LLC Company Information Table 96. GNC Holdings, LLC Business Overview Table 97. GNC Holdings, LLC Brain Health Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. GNC Holdings, LLC Brain Health Products Product Portfolio Table 99. GNC Holdings, LLC Recent Development Table 100. DSM-Firmenich Company Information Table 101. DSM-Firmenich Business Overview Table 102. DSM-Firmenich Brain Health Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. DSM-Firmenich Brain Health Products Product Portfolio Table 104. DSM-Firmenich Recent Development Table 105. BL Bio Lab Company Information Table 106. BL Bio Lab Business Overview Table 107. BL Bio Lab Brain Health Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. BL Bio Lab Brain Health Products Product Portfolio Table 109. BL Bio Lab Recent Development Table 110. AdvaCare Pharma Company Information Table 111. AdvaCare Pharma Business Overview Table 112. AdvaCare Pharma Brain Health Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. AdvaCare Pharma Brain Health Products Product Portfolio Table 114. AdvaCare Pharma Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Brain Health Products Product Image Figure 2. Global Brain Health Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brain Health Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Brain Health Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Plant Extracts Image Figure 8. Fatty Acids Image Figure 9. Vitamins Image Figure 10. Others Image Figure 11. Global Brain Health Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Brain Health Products Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Brain Health Products Sales Value Share by Type (2021-2032) Figure 14. Online Sales Image Figure 15. Offline Sales Image Figure 16. Global Brain Health Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Brain Health Products Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Brain Health Products Sales Value Share by Application (2021-2032) Figure 19. Global Brain Health Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Brain Health Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Brain Health Products Sales Value (2021-2032) & (US$ Million) Figure 22. North America Brain Health Products Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Brain Health Products Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Brain Health Products Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Brain Health Products Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Brain Health Products Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Brain Health Products Sales Value (2021-2032) & (US$ Million) Figure 28. South America Brain Health Products Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Brain Health Products Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Brain Health Products Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Brain Health Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Brain Health Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Brain Health Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Extracts
  • Fatty Acids
  • Vitamins
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Yuwangpharma
  • Velnex Medicare
  • Unilever Global
  • Synergy CHC
  • Reckitt Benckiser Group plc.
  • Quincy Bioscience
  • Ocean Health Pte Ltd.
  • Neuriva
  • Natural Factors
  • Natrol, LLC.
  • Lifelab Manufacturing
  • GNC Holdings, LLC
  • DSM-Firmenich
  • BL Bio Lab
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Brain Health Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Brain Health Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Brain Health Products Market Dynamics
  1. 2.1 Brain Health Products Industry Trends
  2. 2.2 Brain Health Products Industry Drivers
  3. 2.3 Brain Health Products Industry Opportunities and Challenges
  4. 2.4 Brain Health Products Industry Restraints
3 Brain Health Products Market by Company
  1. 3.1 Global Brain Health Products Company Revenue Ranking in 2025
  2. 3.2 Global Brain Health Products Revenue by Company (2021-2026)
  3. 3.3 Global Brain Health Products Company Ranking (2024-2026)
  4. 3.4 Global Brain Health Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Brain Health Products Company Product Type and Application
  6. 3.6 Global Brain Health Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Brain Health Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Brain Health Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Brain Health Products Market by Type
  1. 4.1 Brain Health Products Type Introduction
  2. 4.1.1 Plant Extracts
  3. 4.1.2 Fatty Acids
  4. 4.1.3 Vitamins
  5. 4.1.4 Others
  6. 4.2 Global Brain Health Products Sales Value by Type
  7. 4.2.1 Global Brain Health Products Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Brain Health Products Sales Value by Type (2021-2032)
  9. 4.2.3 Global Brain Health Products Sales Value Share by Type (2021-2032)
5 Brain Health Products Market by Application
  1. 5.1 Brain Health Products Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Brain Health Products Sales Value by Application
  5. 5.2.1 Global Brain Health Products Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Brain Health Products Sales Value by Application (2021-2032)
  7. 5.2.3 Global Brain Health Products Sales Value Share by Application (2021-2032)
6 Brain Health Products Regional Value Analysis
  1. 6.1 Global Brain Health Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brain Health Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Brain Health Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Brain Health Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Brain Health Products Sales Value (2021-2032)
  7. 6.3.2 North America Brain Health Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Brain Health Products Sales Value (2021-2032)
  10. 6.4.2 Europe Brain Health Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Brain Health Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Brain Health Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Brain Health Products Sales Value (2021-2032)
  16. 6.6.2 South America Brain Health Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Brain Health Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Brain Health Products Sales Value Share by Country, 2025 VS 2032
7 Brain Health Products Country-level Value Analysis
  1. 7.1 Global Brain Health Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Brain Health Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Brain Health Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Brain Health Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Brain Health Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Brain Health Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Brain Health Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Brain Health Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Brain Health Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Brain Health Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Brain Health Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Brain Health Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Brain Health Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Brain Health Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Brain Health Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Brain Health Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Brain Health Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Brain Health Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Brain Health Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Brain Health Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Brain Health Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Brain Health Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Brain Health Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Brain Health Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Brain Health Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Brain Health Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Brain Health Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Brain Health Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Brain Health Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Brain Health Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Brain Health Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Brain Health Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Brain Health Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Brain Health Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Brain Health Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Brain Health Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Brain Health Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Brain Health Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Brain Health Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Brain Health Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Brain Health Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Brain Health Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Brain Health Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Brain Health Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Brain Health Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Brain Health Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Brain Health Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Brain Health Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Brain Health Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Brain Health Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Brain Health Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Brain Health Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Brain Health Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Brain Health Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Brain Health Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Brain Health Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Brain Health Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Brain Health Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Brain Health Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Brain Health Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Brain Health Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Brain Health Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Brain Health Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Brain Health Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Brain Health Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Brain Health Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Brain Health Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Brain Health Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Brain Health Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Brain Health Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Brain Health Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Brain Health Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Brain Health Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Brain Health Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Brain Health Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Brain Health Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Brain Health Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Brain Health Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Brain Health Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Brain Health Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Brain Health Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Brain Health Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Brain Health Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Brain Health Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Brain Health Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Brain Health Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Brain Health Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Brain Health Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuwangpharma
  2. 8.1.1 Yuwangpharma Company Information
  3. 8.1.2 Yuwangpharma Business Overview
  4. 8.1.3 Yuwangpharma Brain Health Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yuwangpharma Brain Health Products Product Portfolio
  6. 8.1.5 Yuwangpharma Recent Developments
  7. 8.2 Velnex Medicare
  8. 8.2.1 Velnex Medicare Company Information
  9. 8.2.2 Velnex Medicare Business Overview
  10. 8.2.3 Velnex Medicare Brain Health Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Velnex Medicare Brain Health Products Product Portfolio
  12. 8.2.5 Velnex Medicare Recent Developments
  13. 8.3 Unilever Global
  14. 8.3.1 Unilever Global Company Information
  15. 8.3.2 Unilever Global Business Overview
  16. 8.3.3 Unilever Global Brain Health Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Unilever Global Brain Health Products Product Portfolio
  18. 8.3.5 Unilever Global Recent Developments
  19. 8.4 Synergy CHC
  20. 8.4.1 Synergy CHC Company Information
  21. 8.4.2 Synergy CHC Business Overview
  22. 8.4.3 Synergy CHC Brain Health Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Synergy CHC Brain Health Products Product Portfolio
  24. 8.4.5 Synergy CHC Recent Developments
  25. 8.5 Reckitt Benckiser Group plc.
  26. 8.5.1 Reckitt Benckiser Group plc. Company Information
  27. 8.5.2 Reckitt Benckiser Group plc. Business Overview
  28. 8.5.3 Reckitt Benckiser Group plc. Brain Health Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Reckitt Benckiser Group plc. Brain Health Products Product Portfolio
  30. 8.5.5 Reckitt Benckiser Group plc. Recent Developments
  31. 8.6 Quincy Bioscience
  32. 8.6.1 Quincy Bioscience Company Information
  33. 8.6.2 Quincy Bioscience Business Overview
  34. 8.6.3 Quincy Bioscience Brain Health Products Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Quincy Bioscience Brain Health Products Product Portfolio
  36. 8.6.5 Quincy Bioscience Recent Developments
  37. 8.7 Ocean Health Pte Ltd.
  38. 8.7.1 Ocean Health Pte Ltd. Company Information
  39. 8.7.2 Ocean Health Pte Ltd. Business Overview
  40. 8.7.3 Ocean Health Pte Ltd. Brain Health Products Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ocean Health Pte Ltd. Brain Health Products Product Portfolio
  42. 8.7.5 Ocean Health Pte Ltd. Recent Developments
  43. 8.8 Neuriva
  44. 8.8.1 Neuriva Company Information
  45. 8.8.2 Neuriva Business Overview
  46. 8.8.3 Neuriva Brain Health Products Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Neuriva Brain Health Products Product Portfolio
  48. 8.8.5 Neuriva Recent Developments
  49. 8.9 Natural Factors
  50. 8.9.1 Natural Factors Company Information
  51. 8.9.2 Natural Factors Business Overview
  52. 8.9.3 Natural Factors Brain Health Products Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Natural Factors Brain Health Products Product Portfolio
  54. 8.9.5 Natural Factors Recent Developments
  55. 8.10 Natrol, LLC.
  56. 8.10.1 Natrol, LLC. Company Information
  57. 8.10.2 Natrol, LLC. Business Overview
  58. 8.10.3 Natrol, LLC. Brain Health Products Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Natrol, LLC. Brain Health Products Product Portfolio
  60. 8.10.5 Natrol, LLC. Recent Developments
  61. 8.11 Lifelab Manufacturing
  62. 8.11.1 Lifelab Manufacturing Company Information
  63. 8.11.2 Lifelab Manufacturing Business Overview
  64. 8.11.3 Lifelab Manufacturing Brain Health Products Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lifelab Manufacturing Brain Health Products Product Portfolio
  66. 8.11.5 Lifelab Manufacturing Recent Developments
  67. 8.12 GNC Holdings, LLC
  68. 8.12.1 GNC Holdings, LLC Company Information
  69. 8.12.2 GNC Holdings, LLC Business Overview
  70. 8.12.3 GNC Holdings, LLC Brain Health Products Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GNC Holdings, LLC Brain Health Products Product Portfolio
  72. 8.12.5 GNC Holdings, LLC Recent Developments
  73. 8.13 DSM-Firmenich
  74. 8.13.1 DSM-Firmenich Company Information
  75. 8.13.2 DSM-Firmenich Business Overview
  76. 8.13.3 DSM-Firmenich Brain Health Products Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DSM-Firmenich Brain Health Products Product Portfolio
  78. 8.13.5 DSM-Firmenich Recent Developments
  79. 8.14 BL Bio Lab
  80. 8.14.1 BL Bio Lab Company Information
  81. 8.14.2 BL Bio Lab Business Overview
  82. 8.14.3 BL Bio Lab Brain Health Products Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BL Bio Lab Brain Health Products Product Portfolio
  84. 8.14.5 BL Bio Lab Recent Developments
  85. 8.15 AdvaCare Pharma
  86. 8.15.1 AdvaCare Pharma Company Information
  87. 8.15.2 AdvaCare Pharma Business Overview
  88. 8.15.3 AdvaCare Pharma Brain Health Products Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AdvaCare Pharma Brain Health Products Product Portfolio
  90. 8.15.5 AdvaCare Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst